View by Specialty

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

Gastroenterology News

SPONSORED CONTENT
Save
SPONSORED CONTENT
October 08, 2024
2 min read
Save

Cincinnati Children’s ranks No. 1 for pediatric gastroenterology, GI surgery

Cincinnati Children’s ranks No. 1 for pediatric gastroenterology, GI surgery

Cincinnati Children’s has claimed the No. 1 spot in the United States for pediatric gastroenterology and GI surgery, according to the 2024-2025 U.S. News & World Report Best Hospitals rankings.

SPONSORED CONTENT
October 08, 2024
2 min read
Save

‘Call to action’: Variation in cirrhosis infections support streamlined antibiotic use

‘Call to action’: Variation in cirrhosis infections support streamlined antibiotic use

Significant variations in global rates of infection, culture-positivity and drug resistance serve as a “call to action” to streamline antibiotic use and improve outcomes among inpatients with cirrhosis, according to researchers.

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

SPONSORED CONTENT
October 07, 2024
1 min read
Save

Honorees announced for third annual Healio Honors recognition program

Honorees announced for third annual Healio Honors recognition program

Healio has announced the 2024 honorees of its peer-to-peer recognition program, Healio Honors.

SPONSORED CONTENT
October 07, 2024
2 min read
Save

Inappropriate antibiotic use driven by ‘knowledge, beliefs, and expectations’

Inappropriate antibiotic use driven by ‘knowledge, beliefs, and expectations’

Despite clinical guidance advising against such use, most individuals said that antibiotics would help treat common symptoms and prevent more serious illness, according to results of a survey of patients seen in primary care and ED clinics.

SPONSORED CONTENT
October 07, 2024
3 min read
Save

COPD plus GERD reduces mortality, ventilation odds in hospitalized patients

COPD plus GERD reduces mortality, ventilation odds in hospitalized patients

BOSTON — The odds for mortality, ventilation and septic shock among adults hospitalized with COPD went down if they also had GERD, according to data presented at the CHEST Annual Meeting.

SPONSORED CONTENT
October 07, 2024
5 min read
Save

Q&A: Integrative risk model may predict Crohn’s development in healthy at-risk individuals

Q&A: Integrative risk model may predict Crohn’s development in healthy at-risk individuals

A new integrative model demonstrated “strong predictive performance” in identifying future risk for Crohn’s disease development among healthy first-degree relatives of patients with CD, according to a researcher.

SPONSORED CONTENT
October 04, 2024
1 min read
Save

FDA approves Cologuard Plus, Exact Sciences’ next generation stool test for CRC screening

FDA approves Cologuard Plus, Exact Sciences’ next generation stool test for CRC screening

The FDA approved Exact Sciences’ Cologuard Plus multitarget stool DNA test to screen adults aged 45 years or older at average risk for colorectal cancer, according to a company press release.

SPONSORED CONTENT
October 04, 2024
2 min read
Save

Hepatic steatosis identified in more than half of younger adults without history of MASLD

Hepatic steatosis identified in more than half of younger adults without history of MASLD

Hepatic steatosis was prevalent among 52% of adults with or without type 2 diabetes and no known history of metabolic dysfunction-associated steatotic liver disease, according to findings published in Obesity.

SPONSORED CONTENT
October 04, 2024
2 min read
Save

Socioeconomic status, rurality may represent ‘unique barriers’ to CRC screening uptake

Socioeconomic status, rurality may represent ‘unique barriers’ to CRC screening uptake

Despite a twofold increase in colorectal cancer screening among average-risk individuals aged 45 to 49 years after the 2021 recommendation, disparities in socioeconomic status and locality underscore the need for targeted interventions.

SPONSORED CONTENT
October 03, 2024
1 min read
Save

FDA grants breakthrough status to Sagimet’s denifanstat to treat MASH with fibrosis

FDA grants breakthrough status to Sagimet’s denifanstat to treat MASH with fibrosis

The FDA granted breakthrough designation to Sagimet Biosciences’ denifanstat for the treatment of patients with metabolic dysfunction-associated steatohepatitis and moderate to advanced fibrosis, according to a company press release.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails